Boston Scientific expects ‘dramatic shift’ to pulsed field ablation to fuel fast growth through 2026

Boston Scientific has set bullish growth targets for 2024 to 2026, according to analysts. The company is forecasting that a “dramatic shift” to pulsed field ablation will increase its organic revenues by 8% to 10% over the period.